series-b
Stage
1
Investors
About
Santa Ana Bio develops precision immunology therapies, including engineered antibodies targeting autoimmune and inflammatory diseases by modulating specific immune cell pathways.
Explore Santa Ana Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.